Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07232043 · ClinicalTrials.gov registry record · NA
ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs
A NA study, sponsored by Dana-Farber Cancer Institute.
- Not yet
- Registry status
- NA
- Development phase
- 70,000
- Enrollment target
NCT07232043: Clinical Trial NA study, sponsored by Dana-Farber Cancer Institute.
NCT07232043 is a NA study that has not yet begun recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 70,000 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (4893% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07232043, a NA study, has not yet begun recruiting, sponsored by Dana-Farber Cancer Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70,000 participants
- Enrollment target
Study Summary
This study aims to develop and evaluate ACTIVATE, an AI-driven tool for clinical trial information and viability assessment using electronic health records (EHRs). The project will leverage retrospective and prospective EHR data to build and validate algorithms that identify potentially eligible participants for clinical trials and facilitate trial matching.
Primary Outcome
The effect of TrialMatch notifications is defined as the proportion of new systemic therapy starts which are clinical trials.
Interventions
- OTHER MatchMiner-AI Artificial Intelligence Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70,000 participants |
| Start Date | 2026-06 |
| Est. Completion | 2030-06-30 |
| Phase | NA |
What is known before NCT07232043 opens enrollment
NCT07232043 is an interventional study that assigns participants to a tested intervention. Its 70,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (4893% higher).
The record links to 0 conditions, and to 1 intervention - of which MatchMiner-AI Artificial Intelligence Tool is the first listed.
NCT07232043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07232043 about?
NCT07232043 is a clinical study titled "ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs". This study aims to develop and evaluate ACTIVATE, an AI-driven tool for clinical trial information and viability assessment using electronic health records (EHRs). The project will leverage retrospective and prospective EHR data to build and validate algorithms that identify potentially eligible par...
What is the current status of trial NCT07232043?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70,000 participants. The study started on 2026-06. Estimated completion is 2030-06-30.
What interventions are being tested in trial NCT07232043?
The interventions under investigation include: MatchMiner-AI Artificial Intelligence Tool (OTHER).
Who is sponsoring clinical trial NCT07232043?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07232043's enrollment target sits among peer trials
70,000 4th of 2000 higher than 1,997 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00009633 · 68,000 participants
Follow-up Visit of High Risk Infants
- NCT06903897 · 68,000 participants · NA
Social Needs Screening and Chronic Diseases Study (WE CARE)
- NCT02402244 · 75,000 participants
Project: Every Child for Younger Patients With Cancer
- NCT02803242 · 75,000 participants
COPD Patient-Powered Research Network
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia